PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16227744-7	2005	In the docetaxel treated group at its MTD (33 mg/kg/dose, q 6 d x 3, iv), all of the animals were tumor-free survivors on Day 62 after xenografting.	Docetaxel	7-16	metallothionein 1E	Homo sapiens	38-41	
12468349-10	2002	The MTD was reached at docetaxel 35 mg/m(2) and carboplatin AUC 2 mg/mL.min.	Docetaxel	23-32	metallothionein 1E	Homo sapiens	4-7	
16127289-5	2005	RESULTS: The MTD was 35 mg/m(2)/week for docetaxel and 14 mg/m(2)/week for PEG-LD.	Docetaxel	41-50	metallothionein 1E	Homo sapiens	13-16	
12469168-8	2003	The 13 mg/m(2)/week docetaxel dose level was defined as the MTD causing grade 3 mucositis in 4 out of 8 patients.	Docetaxel	20-29	metallothionein 1E	Homo sapiens	60-63	
11408509-5	2001	Without G-CSF, the MTD was docetaxel 60 mg/m(2) and Doxil 30 mg/m(2) every 3 weeks; only 1 (7%) out of 15 patients treated at this dose level had cycle 1 DLT.	Docetaxel	27-36	metallothionein 1E	Homo sapiens	19-22